{"url_path":"/sec/ndra/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","accession_number":"0001213900-26-057680","cik":"0001681682","ticker":"NDRA","issuer_name":"ENDRA Life Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","primary_entity_key":"0001681682","primary_entity_name":"ENDRA Life Sciences Inc."},"word_count":416,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE\nCOMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 10-Q**\n\n \n\n**(Mark One)**\n\n☒\n**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026**\n\n \n\n**OR**\n\n \n\n☐\n**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**COMMISSION FILE NUMBER\n001-37969**\n\n \n\n**ENDRA LIFE SCIENCES INC.**\n\n*(Exact name of registrant as specified in its charter)*\n\n \n\n**Delaware**   **26-0579295**\n\n*(State of incorporation)*   *(I.R.S. Employer Identification No.)*\n\n \n\n**3600 Green Court,\nSuite 350, Ann Arbor, MI 48105-1570**\n\n*(Address of principal executive office)*(*Zip code*)\n\n \n\n**(734) 335-0468**\n\n*(Registrant’s telephone number, including\narea code)*\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange on which registered**\n\nCommon Stock, par value $0.0001 per share     NDRA     The Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether\nthe registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the\npreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such\nfiling requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate by check mark whether\nthe registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T\n(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit\nsuch files). Yes ☒ No ☐\n\n \n\nIndicate by check mark whether\nthe registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth\ncompany. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act:\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated Filer ☒ Smaller reporting company ☒\n\n    Emerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company\n(as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nAs of May 15, 2026, there were 1,270,077 shares of our common\nstock, par value $0.0001 per share, outstanding.\n\n \n\n \n\n** **\n\n \n\n \n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n \n \n**Page**\n\n \n \n \n\n**PART I - FINANCIAL INFORMATION**\n1"}